Hancock Richard B 4
4 · Avid Bioservices, Inc. · Filed Dec 18, 2023
Insider Transaction Report
Form 4
Hancock Richard B
Director
Transactions
- Purchase
Common Stock, $0.001 par value
2023-12-15$5.86/sh+23,000$134,734→ 78,760 total - Exercise/Conversion
Restricted Stock Units
2023-12-14−9,612→ 7,014 total→ Common Stock (9,612 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2023-12-14+9,612→ 55,760 total - Award
Restricted Stock Units
2023-12-14+26,756→ 33,770 total→ Common Stock (26,756 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $5.825 to $5.90. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- [F3]RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023.
- [F4]Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
- [F5]RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date.